Neuromuscular disease drugs

These companies develop treatments for inherited muscle diseases, such as Duchenne muscular dystrophy.
+11.8%
over 6 months · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Up over 1 year
6 of 12
Volatility
71%
Calm
Choppy
Profitability
−113%
Low
High
Health and price: against the other tags.